Texas Attorney General Sues Acetaminophen Producers Regarding Autism Spectrum Claims
The top legal official in Texas Ken Paxton is suing the manufacturers of Tylenol, claiming the corporations concealed alleged dangers that the drug presented to pediatric neurological development.
The lawsuit comes thirty days after Former President Trump advocated an unverified association between taking Tylenol - also known as paracetamol - while pregnant and autism in children.
The attorney general is filing suit against the pharmaceutical giant, which once produced the medication, the sole analgesic approved for expectant mothers, and the current manufacturer, which presently makes it.
In a declaration, he said they "misled consumers by making money from discomfort and pushing pills regardless of the dangers."
Kenvue asserts there is insufficient reliable data tying acetaminophen to autism.
"These manufacturers lied for decades, knowingly endangering numerous people to line their pockets," the attorney general, from the Republican party, said.
The manufacturer stated officially that it was "seriously troubled by the perpetuation of misinformation on the reliability of acetaminophen and the possible consequences that could have on the welfare of women and children in America."
On its official site, Kenvue also said it had "regularly reviewed the pertinent research and there is no credible data that indicates a verified association between taking paracetamol and autism."
Associations acting on behalf of medical professionals and medical practitioners share this view.
ACOG has declared acetaminophen - the main ingredient in acetaminophen - is one of the few options for women during pregnancy to manage discomfort and elevated temperature, which can pose major wellness concerns if left untreated.
"In over twenty years of investigation on the consumption of acetaminophen in gestation, zero credible investigations has definitively established that the consumption of acetaminophen in any trimester of pregnancy causes neurological conditions in offspring," the organization stated.
The court filing mentions latest statements from the Trump administration in arguing the medication is potentially dangerous.
Recently, the former president generated worry from health experts when he advised expectant mothers to "struggle intensely" not to take Tylenol when sick.
Federal regulators then issued a notice that physicians should think about restricting the consumption of acetaminophen, while also mentioning that "a causal relationship" between the drug and autism in minors has remains unverified.
The Health Department head Robert F Kennedy Jr, who oversees the Food and Drug Administration, had promised in spring to conduct "a massive testing and research effort" that would identify the cause of autism in a limited time.
But specialists cautioned that finding a single cause of autism spectrum disorder - considered by experts to be the consequence of a complex mix of genetic and environmental factors - would prove challenging.
Autism is a category of lifelong neurodivergence and disability that influences how individuals experience and relate to the surroundings, and is diagnosed using physician assessments.
In his legal document, the attorney general - a Trump ally who is running for US Senate - alleges the manufacturer and J&J "willfully ignored and attempted to silence the evidence" around acetaminophen and autism spectrum disorder.
The case seeks to make the corporations "eliminate any marketing or advertising" that states Tylenol is reliable for women during pregnancy.
The Texas lawsuit mirrors the concerns of a assembly of guardians of young ones with autism spectrum disorder and attention deficit hyperactivity disorder who took legal action against the producers of acetaminophen in 2022.
A federal judge rejected the case, declaring investigations from the parents' expert witnesses was not conclusive.